Evidence map›Paper›PMID 26578517›Full record

ArticleThe Journal of biological chemistry2016

Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.

Tatsuya Tominaga, Rajesh K Dutta, Darukeshwara Joladarashi, Toshio Doi, Janardan K Reddy, Yashpal S Kanwar

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. American journal of physiology. Renal physiology · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Diabetes · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tatsuya TominagaFrom the Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 and.
Rajesh K DuttaFrom the Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 and.
Darukeshwara JoladarashiFrom the Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 and.
Toshio Doithe Department of Nephrology, University of Tokushima, Tokushima, Japan.
Janardan K ReddyFrom the Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 and.
Yashpal S KanwarFrom the Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 and y-kanwar@northwestern.edu.
Northwestern University · USTokushima University · JP

Funding

Pathogenesis of Diabetic NephropathyR01DK060635 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI QUAGGIN, SUSAN E. · 2002 to 2023
$6.6M
NIDDK NIH HHS DK60636NIDDK NIH HHS R01 DK060635
6 · The paper itself

Abstract

The kidney is one of the target organs for various metabolic diseases, including diabetes, metabolic syndrome, and obesity. Most of the metabolic studies underscore glomerular pathobiology, although the tubulo-interstitial compartment has been underemphasized. This study highlights mechanisms concerning the pathobiology of tubular injury in the context of myo-inositol oxygenase (Miox), a tubular enzyme. The kidneys of mice fed a high fat diet (HFD) had increased Miox expression and activity, and the latter was related to phosphorylation of serine/threonine residues. Also, expression of sterol regulatory element-binding protein1 (Srebp1) and markers of cellular/nuclear damage was increased along with accentuated apoptosis and loss of tubular brush border. Similar results were observed in cells treated with palmitate/BSA. Multiple sterol-response elements and E-box motifs were found in the miox promoter, and its activity was modulated by palmitate/BSA. Electrophoretic mobility and ChIP assays confirmed binding of Srebp to consensus sequences of the miox promoter. Exposure of palmitate/BSA-treated cells to rapamycin normalized Miox expression and prevented Srebp1 nuclear translocation. In addition, rapamycin treatment reduced p53 expression and apoptosis. Like rapamycin, srebp siRNA reduced Miox expression. Increased expression of Miox was associated with the generation of reactive oxygen species (ROS) in kidney tubules of mice fed an HFD and cell exposed to palmitate/BSA. Both miox and srebp1 siRNAs reduced generation of ROS. Collectively, these findings suggest that HFD or fatty acids modulate transcriptional, translational, and post-translational regulation of Miox expression/activity and underscore Miox being a novel target of the transcription factor Srebp1. Conceivably, activation of the mTORC1/Srebp1/Miox pathway leads to the generation of ROS culminating into tubulo-interstitial injury in states of obesity.

Indexed as

Oxidative StressProtein Processing, Post-TranslationalUp-RegulationAnimalsApoptosisCell LineDiabetic NephropathiesDiet, High-FatHumansInositol OxygenaseKidney TubulesMaleMiceObesityOxygenasesPhosphorylationInositol OxygenaseMIOX protein, humanMiox protein, ratOxygenasesProteinsSterol Regulatory Element Binding Protein 1diabetic nephropathyfatty acidkidneykidney metabolismmyo-inositol oxygenaseobesityrenal tubular injury

Identifiers

PMID26578517
PMCPMC4714220
OpenAlexW2239528726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.